期刊文献+

43例骨肉瘤患者预后的多因素分析 被引量:7

Multivariate analysis for prognostic factors among 43 patients with osteosarcoma
下载PDF
导出
摘要 目的:探讨影响骨肉瘤患者预后的相关因素。方法:回顾性分析2005年3月至2007年3月手术治疗并经病理证实的43例骨肉瘤患者的临床资料,包括性别、年龄、部位、病程、化疗前血清碱性磷酸酶水平、术前化疗、En-neking分期、手术方式及远处转移情况等9项相关因素,采用Kaplan-Meier法计算生存率,应用Log-rank检验行单因素分析,COX检验行多因素分析,研究这些因素与骨肉瘤患者3年生存率之间的关系。采用精确概率Fisher检验研究化疗疗效对骨肉瘤患者预后的影响。结果:43例均获随访,28例存活,15例死亡,生存时间6~65个月,平均39.7个月,中位生存时间42个月,3年总生存率65.1%。单因素分析显示,骨肉瘤预后与部位(P=0.010)、Enneking分期(P=0.002)、手术方式(P=0.000)、远处转移(P=0.002)有相关性;COX多因素分析显示Enneking分期(P=0.028)、手术方式(P=0.001)及远处转移(P=0.007)是影响骨肉瘤患者预后的独立因素。Fisher精确检验显示,尽管术前是否行新辅助化疗对预后影响不明显,但是新辅助化疗疗效的好坏是患者预后的重要影响因素(P=0.007)。结论:骨肉瘤预后与En-neking分期、手术方式及远处转移密切相关,早期发现及充分切除肿瘤是提高骨肉瘤预后可干预措施。 Objective:To determin the prognostic factors that influence survival in patients with osteosarcma.Methods:The clinical data of 43 patients with osteosarcoma between March 2005 and March 2007 were retrospectively reviewed.Patient's sex,age,tumor site,course of disease,serum alkaline phosphatase (AKP) level,preoperative chemotherapy,Enneking surgical stage,surgical method,distant metastasis were analyzed by Kaplan-Meier method,Log-rank test and COX regression model.Kaplan-Meier method was used to calculate the 3-years survival rate,and Log-rank test was used to determin prognostic factors related with survival rate,and COX regression model was used to find the independent prognostic factors.The effect of neoadjuvant chemotherapy on the prognosis of osteosarcoma was analyzed by Fisher exact test.Results:All the patients were followed up.Twenty-eight patients were alive,while 15 patients were dead.The survival time ranged from 6 to 65 months with a median survival of 42 months.Overall 3-year survival rate was 65.1%.Univariate analysis revealed that the prognosis of osteosarcoma was significantly related to tumor site (P=0.010),Enneking surgical stage (P=0.002),surgical method (P=0.000) and distant metastasis (P=0.002).Multivariate analysis by COX regression model suggested Enneking surgical stage (P=0.028),surgical method (P=0.001) and distant metastasis (P=0.007) were the independent prognostic factors.Though the preoperative chemotherapy was unrelated to the survival of osteosarcoma,the sensitivity to preoperative chemotherapy was an important factor that affected the prognosis of osteosarcoma (P=0.007).Conclusion:The prognosis of osteosarcoma was significantly correlated with Enneking surgical stage,surgical method and distant metastasis,early detection and wide excision were interventional methods to improve the survival of osteosarcoma.
出处 《中国骨伤》 CAS 2011年第12期982-986,共5页 China Journal of Orthopaedics and Traumatology
关键词 骨肉瘤 预后 多因素分析 Osteosarcoma Prognosis Multivariate analysis
  • 相关文献

参考文献17

  • 1Picci P.Osteosarcoma(osteogenic sarcoma)[J].Orphanet J Rare Dis,2007,23:2-6.
  • 2Longhi A,Errani C,De Paolis M,et al.Primary bone osteoscarcoma in the pediatric age:state of the art[J].Cancer Treat Rev,2006,32(6):423-436.
  • 3Chou AJ,Gorlick R.Chemotherapy resistance in osteosarcoma:current challenges and future directions[J].Expert Rev Anticancer Ther,2006,6(7):1075-1085.
  • 4Enneking WF,Spanier SS,Goodman MA.A system for the surgical staging of musculoskeletal sarcoma[J].Clin Orthop Relat Res,1980,(153):106-120.
  • 5Rosen G.Preoperative(neoadjuvant)chemotherapy for osteogenic sarcoma:a ten-year experience[J].Orthopedics,1985,8:659-664.
  • 6Bacci G,Picci P,Briccoli A,et al.Osteosarcoma of the extremity metastatic at presentation:results achieved in26patients treated with combined therapy(primary chemotherapy followed by simultaneous resection of the primary and metastatic lesions)[J].Tumori,1992,78(3):200-206.
  • 7Kaste SC,Pratt CB,Cain AM,et al.Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis:imaging features[J].Cancer,1999,86(8):1602-1608.
  • 8林秾,叶招明,李玢,李伟栩,陶惠民,杨迪生.成人骨肉瘤的临床特点及预后影响因素[J].中华骨科杂志,2009,29(8):717-722. 被引量:22
  • 9Goorin AM,Harris MB,Bernstein M,et al.PhaseⅡ/Ⅲtrial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma:a pediatric oncology group trial[J].J Clin Oncol,2002,20(2):426-433.
  • 10Ferrari S,Briccoli A,Mercuri M,et al.Postrelapse survival in osteosarcoma of the extremities:prognostic factors for long-term survival[J].J Clin Oncol,2003,21(4):710-715.

二级参考文献26

  • 1Ferrari S, Smeland S, Mercuri M, et al. Neoadjuvant chemotherapy with high-dose ifosfamide,high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity : A joint study by the Italian and Scandinavian sarcoma groups. J Clin Oncol,2005,23 :8845-8852.
  • 2Bacci G,Forni C, Ferrair S, et al. Neoadjuvant chemotherapy for osteosarcoma of extremity:Intensiflcation of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome. J Pediatr Hematol Oncol,2003,25:845-853.
  • 3Patel SJ, Lynch JW Jr,Johnson T, et al. Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults. Am J Clin Oncol,2002,25:489-495.
  • 4Bacci G,Longhi A,Fagioli F,et al. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute. Eur J Cancer,2005,41:2836-2845.
  • 5Wiliins RM, Cullen JW, Camozzi AB, et al. Improved survival in primary nonmetastatic pediatric osteosarcoma of the extremity. Clin Orthop Relat Res,2005,438:128-136.
  • 6Bacci G, Mercuri M, Longhi A, et al. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosareoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer, 2005,41 :2079-2085.
  • 7Goorin AM, Schwartzentruber D J, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncolong group study POG-8651. J Clin Oncol,2003,21:1574-1580.
  • 8Eselgrim M, Grunert H, Kuhne T, et al. Dose intensity of chemotherapy for osteosarcoma and outcome in the cooperative osteosarcoma study group(COSS) trials. Pediatr Blood Cancer. 2006,47:42-50.
  • 9Delepine N, Delepine G, Bacci G, et al. Infuence of methotrexate dose intensity on outcome of patients with high grade osteosarcona. Cancer,1996,78:2127-2135.
  • 10Bramwell VH, Burgers M, Sneath R, et al. A comparison of two short intensive adjuvant chemotherapy regiments in operable osteosareoma of limbs in children and young adult:The first study of the European osteosareoma intergroup. J Clin Oncol, 1992,10 : 1579-1591.

共引文献26

同被引文献30

  • 1喻紫晨,肖兢,徐海声.四肢骨肉瘤患者的治疗及预后分析[J].实用癌症杂志,2014,29(2):199-201. 被引量:17
  • 2彭丹,张庆,张湘生,黎志宏.骨肉瘤致病理性骨折26例治疗体会[J].医学临床研究,2005,22(8):1132-1133. 被引量:1
  • 3林峰,董扬,唐暁春,赵晖,蔡迅,姚阳.IIB期骨肉瘤新辅助化疗疗效及预后的临床分析[J].肿瘤,2006,26(11):1011-1014. 被引量:3
  • 4梁鹏,宋建民.骨肉瘤化疗进展[J].中国骨伤,2007,20(1):67-69. 被引量:6
  • 5邓侠进 梁国桢.软组织肿瘤病理学[M].贵阳:贵州人民出版社,1988..
  • 6Sampo M, Koivikko M, Taskinen M, et al. Incidence, epidemiology and treatment results of osteosarcoma in Finland-ct nationwide population- based study. Acta Oncol,2011,50 : 1206-1214.
  • 7Kim HJ, Chalmers PN, Morris CD. Pediatric osteogenic sarcoma. Curr Opin Pediatr,2010 ,22 :61-66.
  • 8Hameed M, Dorfman H. Primary malignant bone tumors-recent developments. Semin Diagn Pathol,2011,28:86-101.
  • 9Ta HT, Dass CR, Choong PF, et al. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev ,2009,28:247-263.
  • 10Konishi E,Kusuzaki K,Murata H,et al. Extraskeletal osteosarcoma arising in myositis ossificans[J]. Skeletal Radiol,2001,30(1):39-43.

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部